Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Top Cited Papers
Open Access
- 24 February 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 7 (1), 10767
- https://doi.org/10.1038/ncomms10767
Abstract
The cytidine analogues azacytidine and 5-aza-2’-deoxycytidine (decitabine) are commonly used to treat myelodysplastic syndromes, with or without a myeloproliferative component. It remains unclear whether the response to these hypomethylating agents results from a cytotoxic or an epigenetic effect. In this study, we address this question in chronic myelomonocytic leukaemia. We describe a comprehensive analysis of the mutational landscape of these tumours, combining whole-exome and whole-genome sequencing. We identify an average of 14±5 somatic mutations in coding sequences of sorted monocyte DNA and the signatures of three mutational processes. Serial sequencing demonstrates that the response to hypomethylating agents is associated with changes in DNA methylation and gene expression, without any decrease in the mutation allele burden, nor prevention of new genetic alteration occurence. Our findings indicate that cytosine analogues restore a balanced haematopoiesis without decreasing the size of the mutated clone, arguing for a predominantly epigenetic effect.Keywords
This publication has 67 references indexed in Scilit:
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesCell, 2015
- Recurrent somatic mutations in regulatory regions of human cancer genomesNature Genetics, 2015
- High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)Leukemia, 2015
- Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemiaJCI Insight, 2015
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA SequenceNew England Journal of Medicine, 2014
- HTSeq—a Python framework to work with high-throughput sequencing dataBioinformatics, 2014
- MethylSig: a whole genome DNA methylation analysis pipelineBioinformatics, 2014
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3APublished by American Society of Hematology ,2011
- Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemiaJCI Insight, 2011
- Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasiaBlood, 2006